Proxy Results Form 8 K

Item 5.07

Submission of Matters to a Vote of Security Holders.

On September 27, 2024, Molecular Templates, Inc. (the "Company") held its 2024 annual meeting of stockholders (the "Annual Meeting"). At the Annual Meeting, a quorum of 4,676,739 shares of the Company's common stock, or 71.03% of the outstanding shares of common stock entitled to vote as of the record date of August 1, 2024, were present in person or represented by proxy. At the Annual Meeting, the stockholders: (1) elected Corsee Sanders, Ph.D. to the Company's Board of Directors as a Class II director for a term of three years to serve until the 2027 annual meeting of stockholders and until her successor is elected and qualified or until her earlier death, resignation or removal ("Election of Director"); (2) ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 ("Auditor Ratification"); and (3) approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement for the meeting ("Advisory Vote on Executive Compensation"). A more complete description of each of these matters is set forth in the Company's proxy statement.

The number of votes cast in favor or against by the stockholders and the number of abstentions and the number of broker non-voteson each of the foregoing matters are set forth below.

1.	Election of Director

Nominee		Shares Voted For		Shares Voted Against		Shares Abstaining		Broker Non-votes
Corsee Sanders, Ph.D.		3,031,323		553,546		139		1,091,731

2.	Auditor Ratification

Shares Voted For		Shares Voted Against		Shares Abstaining
4,639,921		28,744		8,074

3.	Advisory Vote on Executive Compensation

Shares Voted For		Shares Voted Against		Shares Abstaining		Broker Non-votes
3,561,675		22,865		468		1,091,731

2